Acetyl Tetrapeptide-5
Also known as: Eyeseryl, Ac-bAla-His-Ser-His
Acetylated synthetic tetrapeptide sold as Eyeseryl for under-eye creams aimed at puffiness. A cosmetic ingredient, not an FDA-approved drug.
Last updated
Mechanism of Action
Acetyl tetrapeptide-5 (Ac-beta-Ala-His-Ser-His) is a short synthetic peptide developed by a cosmetic ingredient supplier for the eye area. The manufacturer's proposed mechanisms are inhibition of angiotensin-converting enzyme activity in skin, which is claimed to limit local fluid buildup, and reduced protein glycation, which is claimed to preserve collagen elasticity. These mechanisms come mainly from supplier in vitro data and have not been confirmed in independent, peer-reviewed human studies of the peptide on its own.
- Half-life
- Not well established
- Administration Routes
- Topical
- Research Status
- Research Chemical
Reported Benefits
- Marketed to reduce the look of under-eye puffiness
- Marketed to reduce the look of dark circles
- Supplier in vitro data on anti-glycation activity
- Independent clinical evidence for the peptide alone is lacking
Potential Side Effects
- Mild stinging or redness near the eyes
- Contact irritation from the overall formulation
- Eye irritation if product gets into the eye
Common Dosing
There is no medical dose: acetyl tetrapeptide-5 is a cosmetic ingredient used at low concentrations in finished eye creams and serums, and the formulation is set by the product manufacturer. Follow the product label, and see a clinician for persistent or one-sided eye swelling, which can have medical causes.
The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.
Contraindications
- Known sensitivity to the product or its ingredients
- Broken, infected or inflamed skin around the eye
- Not for use in the eye itself
No documented stacking partners for Acetyl Tetrapeptide-5 yet.
No notable studies catalogued for Acetyl Tetrapeptide-5 yet.